Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05204134 · ClinicalTrials.gov registry record · NA

Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use

A NA study, sponsored by Tandem Diabetes Care.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT05204134 is a NA study that has completed, run by Tandem Diabetes Care. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05204134, a NA study, has completed, sponsored by Tandem Diabetes Care.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

Obtain preliminary safety and performance data on a settings initialization and adaptation algorithm used in conjunction with closed-loop control.

Interventions

  • DEVICE Automated Insulin Delivery Settings Initialization and Adaptation Algorithm

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2022-03-24
Est. Completion 2022-09-29
Phase NA

Sponsor

Tandem Diabetes Care

13 total trials

What the Registry Record Tells You About NCT05204134

The ClinicalTrials.gov registry entry for NCT05204134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Automated Insulin Delivery Settings Initialization and Adaptation Algorithm is the first listed.

NCT05204134 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05204134 about?

NCT05204134 is a clinical study titled "Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use". Obtain preliminary safety and performance data on a settings initialization and adaptation algorithm used in conjunction with closed-loop control.

What is the current status of trial NCT05204134?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-03-24. Estimated completion is 2022-09-29.

What interventions are being tested in trial NCT05204134?

The interventions under investigation include: Automated Insulin Delivery Settings Initialization and Adaptation Algorithm (DEVICE).

Who is sponsoring clinical trial NCT05204134?

This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.